XML 40 R64.htm IDEA: XBRL DOCUMENT v3.20.1
Equity (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Jun. 14, 2017
Jun. 01, 2017
Aug. 31, 2019
Feb. 19, 2018
May 17, 2017
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Feb. 04, 2020
Mar. 31, 2019
Dec. 31, 2016
Statement Line Items [Line Items]                      
Financial liability           $ 7,558 $ 4,731        
Finance income           8,765 54 $ 102      
Influence on equity           11,602 15,572 [1] 18,166     $ 19,303
Convertible promissory notes [Member]                      
Statement Line Items [Line Items]                      
Consideration received, net           4,276          
Financial liability           11,609          
Convertible notes           7,333          
Loss on conversion price           2,003          
Remaining financial liabilities           $ 2,905          
Convertible promissory notes [Member] | Non-adjusting events after reporting period [member]                      
Statement Line Items [Line Items]                      
Aggregate principal amount                 $ 200    
Treasury Shares [Member]                      
Statement Line Items [Line Items]                      
Ordinary shares issued           527,032          
Constituted issued and paid up share capital percentage           25.00%          
Influence on equity           $ (1,509) $ (1,509) $ (1,509)     $ (1,509)
ADS [Member] | Non-adjusting events after reporting period [member] | Warrants [Member]                      
Statement Line Items [Line Items]                      
Exercise price                 $ 1.914    
ADS [Member] | Convertible promissory notes [Member] | Non-adjusting events after reporting period [member]                      
Statement Line Items [Line Items]                      
Conversion price                 $ 1.74    
Ordinary Shares [Member]                      
Statement Line Items [Line Items]                      
Gross proceeds from offering       $ 10,560              
Financial liability           793          
Finance income           $ 9,327          
Right to purchase exercised ordinary shares                   1,881  
Ordinary Shares [Member] | Investor [Member]                      
Statement Line Items [Line Items]                      
Right to purchase exercised ordinary shares                   1,881  
Private Placement [Member]                      
Statement Line Items [Line Items]                      
Ordinary shares issued           30,472,400          
Financial liability           $ 2,893          
Finance income           620          
Aggregate principal amount     $ 4,276     $ 1,767          
Additional debt amount     2,700                
Gross proceeds     $ 7,000                
Securities purchase agreement, description           Accordingly, from the consideration received, approximately $1,569,000 was attributed to the convertible notes of the first tranche, $1,902,000 was attributed to the warrants of the first tranche, and a total of approximately $805,000 was attributed to the rights with respect to the second and third tranches.          
Maturity date           Mar. 04, 2021          
Conversion price           $ 2.90          
Private Placement [Member] | Ordinary Shares [Member]                      
Statement Line Items [Line Items]                      
Ordinary shares issued 4,078,759 4,044,050     3,430,000            
Exercise price $ 1.17 $ 1.17     $ 1.17            
Consideration received, net $ 4,800 $ 4,700     $ 4,000 $ 12,420          
Public Offering [Member] | Ordinary Shares [Member]                      
Statement Line Items [Line Items]                      
Net issuance consideration, total       1,224              
Attributed to warrants       $ 10,201              
Ordinary shares issued       80,000,000              
Gross proceeds from offering       $ 1,440              
Consideration received, net       $ 12,000              
Warrants description       80,000,000 non-tradable warrants (exercisable into 1,600,000 ADSs) with an exercise price of $8.625 per ADS and term of 5 years and 60,000,000 non-tradable rights to purchase shares (exercisable into 1,200,000 ADSs) with an exercise price of $7.5 per ADS and term of 6 months.              
Public Offering [Member] | Ordinary Shares [Member] | ADS [Member]                      
Statement Line Items [Line Items]                      
Net issuance consideration, total       $ 216              
Attributed to warrants       $ 1,799              
Ordinary shares issued       16,000,000              
[1] See Note 2.C regarding initial application of International Financial Reporting Standard ("IFRS") 16, Leases. According to the transitional method that was chosen, comparative data were not restated.